nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.21682/2311-1267-2025-12-4-83-88nodgo-1236Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL CASESУротелиальная карцинома мочевого пузыря у пациентки 10 лет: клиническое наблюдение и обзор литературыUrothelial carcinoma of the bladder in a 10-year-old female patient: a case report and literature reviewhttps://orcid.org/0000-0002-4699-1730ФедороваА. С.FedorovaA. S.

врач-патологоанатом патологоанатомического отделения 

119571, Москва, Ленинский просп., 117

Pathologist, Pathology Department

117 Leninskiy Prosp., Moscow, 117997

fyodorova_hannah@mail.ruhttps://orcid.org/0009-0008-9895-852XМурадоваВ. А.MuradovaV. A.

врач-патологоанатом патологоанатомического отделения 

125284, Москва, 2-й Боткинский проезд, 5

Pathologist, Pathology Department 

5 2nd Botkinskiy Proyezd, Moscow, 125284

vayoriii@gmail.comhttps://orcid.org/0000-0002-9788-0504МитрофановаА. М.MitrofanovaA. M.

врач-патологоанатом патологоанатомического отделения 

117997, Москва, ул. Саморы Машела, 1

Pathologist, Pathology Department 

1 Samory Mashela St., Moscow, 117997

pathmorf@mail.ruhttps://orcid.org/0000-0002-9496-3136ТаракановаА. В.TarakanovaA. V.

врач-патологоанатом патологоанатомического отделения 

117997, Москва, ул. Саморы Машела, 1

Pathologist, Pathology Department

1 Samory Mashela St., Moscow, 117997

sequaciou@gmail.comhttps://orcid.org/0009-0000-8333-1304СеменовА. А.SemenovA. A.

врач – детский онколог, детский хирург, и. о. заведующего детским онкологическим отделением 

398042, Липецк, ул. Московская, 6а

Pediatric Oncologist, Pediatric Surgeon, Acting Head of the Pediatric Oncology Department 

6a Moskovskaya St., Lipetsk, 398042

semen.84@list.ruhttps://orcid.org/0009-0002-3144-5558СоколоваВ. Э.SokolovaV. E.

заведующая патологоанатомическим отделением 

119571, Москва, Ленинский просп., 117

Head of the Pathology Department

117 Leninskiy Prosp., Moscow, 117997

valeriiasklv@mail.ruhttps://orcid.org/0000-0001-7732-8184КоноваловД. М.KonovalovD. M.

к.м.н., заведующий патологоанатомическим отделением; доцент кафедры патологической анатомии  

117997, Москва, ул. Саморы Машела, 1

125993, Москва, ул. Баррикадная, 2/1, стр. 1

Cand. of Sci. (Med.), Head of the Pathology Department; Associate Professor of the Department of Pathological Anatomy

1 Samory Mashela St., Moscow, 117997

Bldg. 1, 2/1 Barrikadnaya St., Moscow, 125993

dmk_nadf@mail.ruРДКБ – филиал ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РоссииРоссияRussian Children’s Clinical Hospital – Branch of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaRussian FederationГБУЗ г. Москвы «Московский многопрофильный научно-клинический центр имени С.П. Боткина» Департамента здравоохранения г. МосквыРоссияMoscow Botkin Multidisciplinary Scientific and Clinical Center, Healthcare Department of the Government of MoscowRussian FederationФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава РоссииРоссияDmitry Rogachev National Medical Research Center of Pediatric HematologyRussian FederationГУЗ «Областная детская больница»РоссияLipetsk Regional Children’s HospitalRussian FederationФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; Russian Medical Academy of Continuous Professional Education, Ministry of Health of RussiaRussian Federation2025140120261248388Copyright © Федорова А.С., Мурадова В.А., Митрофанова А.М., Тараканова А.В., Семенов А.А., Соколова В.Э., Коновалов Д.М., 20262026Федорова А.С., Мурадова В.А., Митрофанова А.М., Тараканова А.В., Семенов А.А., Соколова В.Э., Коновалов Д.М.Fedorova A.S., Muradova V.A., Mitrofanova A.M., Tarakanova A.V., Semenov A.A., Sokolova V.E., Konovalov D.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/1236

Уротелиальные карциномы крайне редко встречаются у пациентов детского возраста. В отличие от взрослых пациентов у детей экзогенные факторы риска не играют ведущей роли в развитии данного заболевания. В настоящей статье представлен клинический случай уротелиальной карциномы мочевого пузыря с рецидивирующим течением у пациентки 10 лет.

Urothelial carcinomas are extremely rare in pediatric patients. Unlike in adults, exogenous risk factors do not play a leading role in the development of this disease in children. This article presents a clinical case of urothelial bladder carcinoma with a relapsing course in a 10-year-old patient.

уротелиальная карциномамочевой пузырьдетиподросткионкоурологияurothelial carcinomabladderchildrenadolescentsoncourologyReferencesШахзадова А.О., Старинский В.В., Лисичникова И.В. Состояние онкологической помощи населению России в 2022 году. Сибирский онкологический журнал. 2023;22(5):5–13. doi: 10.21294/1814-4861-2023-22-5-5-13.Shakhzadova A.O., Starinsky V.V., Lisichnikova I.V. Cancer care to the population of Russia in 2022. Sibirskij onkologicheskij zhurnal = Siberian Journal of Oncology. 2023;22(5):5–13. (In Russ.)].Рыков М.Ю., Севрюков Д.Д., Вилкова А.С. Злокачественные новообразования у детей: клинические проявления и диагностика. Вопросы современной педиатрии. 2017;16(5):370–82. doi: 10.15690/vsp.v16i5.1801.Siegel R.L., Giaquinto A.N., Ahmedin J. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. doi: 10.3322/caac.21820.Steliarova-Foucher E., Colombet M., Ries L.A.G., Moreno F., Dolya A., Bray F., Hesseling P., Shin H.Y., Stiller C.A.; IICC-3 contributors. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–31. doi: 10.1016/S1470-2045(17)30186-9.Rykov M.Yu., Sevryukov D.D., Vilkova A.S. Malignant neoplasms in children: clinical manifestations and diagnosis. Voprosy sovremennoj pediatrii = Current Pediatrics. 2017;16(5):370–82. (In Russ.)].Gutierrez J.C., Housri N., Koniaris L.G., Fischer A.C., Sola J.E. Malignant breast cancer in children: a review of 75 patients. J Surg Res. 2008;147(2):182–8. doi: 10.1016/j.jss.2008.03.026.Steliarova-Foucher E., Colombet M., Ries L.A.G., Moreno F., Dolya A., Bray F., Hesseling P., Shin H.Y., Stiller C.A.; IICC-3 contributors. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–31. doi: 10.1016/S1470-2045(17)30186-9.Deepak J., Raj M., Brijesh L. Colorectal carcinoma in pediatric age group-epidemiological paradigm. Ann Oncol. 2014;25(Supple):ii95.Gutierrez J.C., Housri N., Koniaris L.G., Fischer A.C., Sola J.E. Malignant breast cancer in children: a review of 75 patients. J Surg Res. 2008;147(2):182–8. doi: 10.1016/j.jss.2008.03.026.Balzer B.W.R., Loo C., Lewis C.R., Trahair T.N., Anazodo A.C. Adenocarcinoma of the lung in childhood and adolescence: a systematic review. J Thorac Oncol. 2018;13(12):1832–41. doi: 10.1016/j.jtho.2018.08.2020.Deepak J., Raj M., Brijesh L. Colorectal carcinoma in pediatric age group-epidemiological paradigm. Ann Oncol. 2014;25(Supple):ii95.Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660.Balzer B.W.R., Loo C., Lewis C.R., Trahair T.N., Anazodo A.C. Adenocarcinoma of the lung in childhood and adolescence: a systematic review. J Thorac Oncol. 2018;13(12):1832–41. doi: 10.1016/j.jtho.2018.08.2020.WHO Classifi cation of Tumours Editorial Board, editor. Urinary and Male Genital Tumours: WHO Classifi cation of Tumours, 5th Edition, Volume 8. Lyon (France): International Agency for Research on Cancer, 2022. 576 p.Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660.Marinoni F., Destro F., Selvaggio G.G.O., Riccipetitoni G. Urothelial carcinoma in children: A case series. Bull Cancer. 2018;105(6):556–61. doi: 10.1016/j.bulcan.2018.03.002.WHO Classifi cation of Tumours Editorial Board, editor. Urinary and Male Genital Tumours: WHO Classifi cation of Tumours, 5th Edition, Volume 8. Lyon (France): International Agency for Research on Cancer, 2022. 576 p.Erikson M.S., Petersen A.C., Andersen K.K., Andreasen A.H., Friis S., Mogensen K., Hermann G.G. National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study. Scand J Urol. 2018;52(5–6):364–70. doi: 10.1080/21681805.2018.1518926.Marinoni F., Destro F., Selvaggio G.G.O., Riccipetitoni G. Urothelial carcinoma in children: A case series. Bull Cancer. 2018;105(6):556–61. doi: 10.1016/j.bulcan.2018.03.002.Saginala K., Barsouk A., Aluru J.S., Rawla P., Padala S.A., Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel). 2020;8(1):15. doi: 10.3390/medsci8010015.Erikson M.S., Petersen A.C., Andersen K.K., Andreasen A.H., Friis S., Mogensen K., Hermann G.G. National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study. Scand J Urol. 2018;52(5–6):364–70. doi: 10.1080/21681805.2018.1518926.Rezaee M.E., Dunaway C.M., Baker M.L., Penna F.J., Chavez D.R. Urothelial cell carcinoma of the bladder in pediatric patients: a systematic review and data analysis of the world literature. J Pediatr Urol. 2019;15(4):309–14. doi: 10.1016/j.jpurol.2019.06.013.Saginala K., Barsouk A., Aluru J.S., Rawla P., Padala S.A., Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel). 2020;8(1):15. doi: 10.3390/medsci8010015.Kamihara J., Bourdeaut F., Foulkes W.D., Molenaar J.J., Mossé Y.P., Nakagawara A., Parareda A., Scollon S.R., Schneider K.W., Skalet A.H., States L.J., Walsh M.F., Diller L.R., Brodeur G.M. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017;23(13):e98–106. doi: 10.1158/1078-0432.CCR-17-0652.Rezaee M.E., Dunaway C.M., Baker M.L., Penna F.J., Chavez D.R. Urothelial cell carcinoma of the bladder in pediatric patients: a systematic review and data analysis of the world literature. J Pediatr Urol. 2019;15(4):309–14. doi: 10.1016/j.jpurol.2019.06.013.Shelmerdine S.C., Lorenzo A.J., Gupta A.A., Chavhan G.B. Pearls and pitfalls in diagnosing pediatric urinary bladder masses. Radiographics. 2017;37(6):1872–91. doi: 10.1148/rg.2017170031.Kamihara J., Bourdeaut F., Foulkes W.D., Molenaar J.J., Mossé Y.P., Nakagawara A., Parareda A., Scollon S.R., Schneider K.W., Skalet A.H., States L.J., Walsh M.F., Diller L.R., Brodeur G.M. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017;23(13):e98–106. doi: 10.1158/1078-0432.CCR-17-0652.Rifat U.N., Hamadalla N.Y., Chiad Safi K.C., Al Habash S.S., Mohammed M. Urothelial bladder tumour in childhood: A report of two cases and a review. Arab J Urol. 2015;13(2):116–21. doi: 10.1016/j.aju.2014.11.002.Shelmerdine S.C., Lorenzo A.J., Gupta A.A., Chavhan G.B. Pearls and pitfalls in diagnosing pediatric urinary bladder masses. Radiographics. 2017;37(6):1872–91. doi: 10.1148/rg.2017170031.Robertson A.G., Kim J., Al-Ahmadie H., Bellmunt J., Guo G., Cherniack A.D., Hinoue T., Laird P.W., Hoadley K.A., Akbani R., Castro M.A.A., Gibb E.A., Kanchi R.S., Gordenin D.A., Shukla S.A., Sanchez-Vega F., Hansel D.E., Czerniak B.A., Reuter V.E., Su X., de Sa Carvalho B., Chagas V.S., Mungall K.L., Sadeghi S., Pedamallu C.S., Lu Y., Klimczak L.J., Zhang J., Choo C., Ojesina A.I., Bullman S., Leraas K.M., Lichtenberg T.M., Wu C.J., Schultz N., Getz G., Meyerson M., Mills G.B., McConkey D.J.; TCGA Research Network; Weinstein J.N., Kwiatkowski D.J., Lerner S.P. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2018;174(4):1033. doi: 10.1016/j.cell.2018.07.036.Rifat U.N., Hamadalla N.Y., Chiad Safi K.C., Al Habash S.S., Mohammed M. Urothelial bladder tumour in childhood: A report of two cases and a review. Arab J Urol. 2015;13(2):116–21. doi: 10.1016/j.aju.2014.11.002.Isharwal S., Audenet F., Drill E., Pietzak E.J., Iyer G., Ostrovnaya I., Cha E., Donahue T., Arcila M., Jayakumaran G., Berger M.F., Rosenberg J.E., Bajorin D.F., Coleman J., Dalbagni G., Reuter V.E., Bochner B.H., Solit D.B., Al-Ahmadie H.A. Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma. Eur Urol Focus. 2019;5(2):201–4. doi: 10.1016/j.euf.2017.07.004.Robertson A.G., Kim J., Al-Ahmadie H., Bellmunt J., Guo G., Cherniack A.D., Hinoue T., Laird P.W., Hoadley K.A., Akbani R., Castro M.A.A., Gibb E.A., Kanchi R.S., Gordenin D.A., Shukla S.A., Sanchez-Vega F., Hansel D.E., Czerniak B.A., Reuter V.E., Su X., de Sa Carvalho B., Chagas V.S., Mungall K.L., Sadeghi S., Pedamallu C.S., Lu Y., Klimczak L.J., Zhang J., Choo C., Ojesina A.I., Bullman S., Leraas K.M., Lichtenberg T.M., Wu C.J., Schultz N., Getz G., Meyerson M., Mills G.B., McConkey D.J.; TCGA Research Network; Weinstein J.N., Kwiatkowski D.J., Lerner S.P. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2018;174(4):1033. doi: 10.1016/j.cell.2018.07.036.Kinde I., Munari E., Faraj S.F., Hruban R.H., Schoenberg M., Bivalacqua T., Allaf M., Springer S., Wang Y., Diaz L.A. Jr, Kinzler K.W., Vogelstein B., Papadopoulos N., Netto G.J. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res. 2013;73(24):7162–7. doi: 10.1158/0008-5472.CAN-13-2498.Isharwal S., Audenet F., Drill E., Pietzak E.J., Iyer G., Ostrovnaya I., Cha E., Donahue T., Arcila M., Jayakumaran G., Berger M.F., Rosenberg J.E., Bajorin D.F., Coleman J., Dalbagni G., Reuter V.E., Bochner B.H., Solit D.B., Al-Ahmadie H.A. Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma. Eur Urol Focus. 2019;5(2):201–4. doi: 10.1016/j.euf.2017.07.004.Pietzak E.J., Bagrodia A., Cha E.K., Drill E.N., Iyer G., Isharwal S., Ostrovnaya I., Baez P., Li Q., Berger M.F., Zehir A., Schultz N., Rosenberg J.E., Bajorin D.F., Dalbagni G., Al-Ahmadie H., Solit D.B., Bochner B.H. Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur Urol. 2017;72(6):952–9. doi: 10.1016/j.eururo.2017.05.032.Kinde I., Munari E., Faraj S.F., Hruban R.H., Schoenberg M., Bivalacqua T., Allaf M., Springer S., Wang Y., Diaz L.A. Jr, Kinzler K.W., Vogelstein B., Papadopoulos N., Netto G.J. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res. 2013;73(24):7162–7. doi: 10.1158/0008-5472.CAN-13-2498.Hurst C.D., Knowles M.A. Mutational landscape of non-muscleinvasive bladder cancer. Urol Oncol. 2022;40(7):295–303. doi: 10.1016/j.urolonc.2018.10.015.Pietzak E.J., Bagrodia A., Cha E.K., Drill E.N., Iyer G., Isharwal S., Ostrovnaya I., Baez P., Li Q., Berger M.F., Zehir A., Schultz N., Rosenberg J.E., Bajorin D.F., Dalbagni G., Al-Ahmadie H., Solit D.B., Bochner B.H. Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur Urol. 2017;72(6):952–9. doi: 10.1016/j.eururo.2017.05.032.Pollard C., Smith S.C., Theodorescu D. Molecular genesis of nonmuscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med. 2010;12:e10. doi: 10.1017/S1462399410001407.Hurst C.D., Knowles M.A. Mutational landscape of non-muscleinvasive bladder cancer. Urol Oncol. 2022;40(7):295–303. doi: 10.1016/j.urolonc.2018.10.015.Aykan S., Yuruk E., Tuken M., Temiz M.Z., Ozsoy S. Rare but lethal disease of childhood: metastatic, muscle invasive bladder cancer. Pediatr Rep. 2015;7(3):5928. doi: 10.4081/pr.2015.5928.Pollard C., Smith S.C., Theodorescu D. Molecular genesis of nonmuscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med. 2010;12:e10. doi: 10.1017/S1462399410001407.Bianchi M., Roghmann F., Becker A., Sukumar S., Briganti A., Menon M., Karakiewicz P.I., Sun M., Noldus J., Trinh Q.D. Agestratifi ed distribution of metastatic sites in bladder cancer: A population-based analysis. Can Urol Assoc J. 2014;8(3–4):E148–58. doi: 10.5489/cuaj.787.Aykan S., Yuruk E., Tuken M., Temiz M.Z., Ozsoy S. Rare but lethal disease of childhood: metastatic, muscle invasive bladder cancer. Pediatr Rep. 2015;7(3):5928. doi: 10.4081/pr.2015.5928.Bianchi M., Roghmann F., Becker A., Sukumar S., Briganti A., Menon M., Karakiewicz P.I., Sun M., Noldus J., Trinh Q.D. Agestratifi ed distribution of metastatic sites in bladder cancer: A population-based analysis. Can Urol Assoc J. 2014;8(3–4):E148–58. doi: 10.5489/cuaj.787.Bianchi M., Roghmann F., Becker A., Sukumar S., Briganti A., Menon M., Karakiewicz P.I., Sun M., Noldus J., Trinh Q.D. Agestratifi ed distribution of metastatic sites in bladder cancer: A population-based analysis. Can Urol Assoc J. 2014;8(3–4):E148–58. doi: 10.5489/cuaj.787.

The authors declare that there are no conflicts of interest present.